Abstract

The expression of recombinant hemagglutinin in plants is a promising alternative to the current egg-based production system for the influenza vaccines. Protein-stabilizing fusion partners have been developed to overcome the low production yields and the high downstream process costs associated with the plant expression system. In this context, we tested the fusion of hydrophobin I to the hemagglutinin ectodomain of the influenza A (H1N1)pdm09 virus controlled by the hybrid En2PMA4 transcriptional promoter to rapidly produce high levels of recombinant antigen by transient expression in agro-infiltrated Nicotiana benthamiana leaves. The fusion increased the expression level by a factor of ∼2.5 compared to the unfused protein allowing a high accumulation level of 8.6% of the total soluble proteins. Hemagglutinin was located in ER-derived protein bodies and was successfully purified by combining an aqueous-two phase partition system and a salting out step. Hydrophobin interactions allowed the formation of high molecular weight hemagglutinin structures, while unfused proteins were produced as monomers. Purified protein was shown to be biologically active and to induce neutralizing antibodies after mice immunization. Hydrophobin fusion to influenza hemagglutinin might therefore be a promising approach for rapid, easy, and low cost production of seasonal or pandemic influenza vaccines in plants.

Highlights

  • Influenza infections are of major concern for public health

  • We investigated hydrophobin fusion as a tool to obtain high-level expression of the recombinant HA ectodomain from the Influenza A/ Texas/05/2009 (H1N1) virus by transient expression in N. benthamiana leaves

  • We found that the latter allowed higher Green Fluorescent Protein (GFP) expression than the former when transiently expressed in N. benthamiana leaves (S2 Fig.)

Read more

Summary

Introduction

Influenza infections are of major concern for public health. Pandemics have caused more than 50 million deaths and cumulatively more have been caused by seasonal infections [1]. The soluble truncated HA from the pandemic A/California/ 04/09 (H1N1) was shown to be safe and immunogenic in a phase I clinical trial [13] Both the VLP and the truncated HA approaches were shown to be a feasible response strategy to pandemics in developing countries, by the stable and transient expression of full-length or truncated HA from an avian H5 influenza strain in Nicotiana tabacum plants [14]. Hydrophobin I (HFBI), a small (,10 kDa) surface-active protein secreted by filamentous fungi, possesses the ability to alter the hydrophobicity of the fusion partner, which can be purified by an aqueous two-phase system (ATPS) [16] This approach has been successfully used in N. benthamiana agro-infiltrated leaves and N. tabacum BY-2 cells for the expression of GFP in ER-derived protein bodies (PB) [17,18]. The immunogenic properties and the potency to induce neutralizing antibodies of the purified antigen were demonstrated by immunological studies in mice

Results
Discussion
Ethics statement
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call